[HTML][HTML] CRISPR-Cas9 targeting of MMP13 in human chondrocytes leads to significantly reduced levels of the metalloproteinase and enhanced type II collagen …
CI Seidl, TA Fulga, CL Murphy - Osteoarthritis and Cartilage, 2019 - Elsevier
Objective To investigate the efficacy of CRISPR-Cas9 mediated editing in human
chondrocytes, and to develop a genome editing approach relevant to cell-based repair …
chondrocytes, and to develop a genome editing approach relevant to cell-based repair …
[HTML][HTML] CRISPR-Cas9 targeting of MMP13 in human chondrocytes leads to significantly reduced levels of the metalloproteinase and enhanced type II collagen …
CI Seidl, TA Fulga, CL Murphy - Osteoarthritis and Cartilage, 2019 - oarsijournal.com
Objective To investigate the efficacy of CRISPR-Cas9 mediated editing in human
chondrocytes, and to develop a genome editing approach relevant to cell-based repair …
chondrocytes, and to develop a genome editing approach relevant to cell-based repair …
CRISPR-Cas9 targeting of MMP13 in human chondrocytes leads to significantly reduced levels of the metalloproteinase and enhanced type II collagen accumulation
CI Seidl, TA Fulga, CL Murphy - Osteoarthritis and …, 2019 - pubmed.ncbi.nlm.nih.gov
Objective To investigate the efficacy of CRISPR-Cas9 mediated editing in human
chondrocytes, and to develop a genome editing approach relevant to cell-based repair …
chondrocytes, and to develop a genome editing approach relevant to cell-based repair …
CRISPR-Cas9 targeting of MMP13 in human chondrocytes leads to significantly reduced levels of the metalloproteinase and enhanced type II collagen accumulation.
CI Seidl, TA Fulga, CL Murphy - Osteoarthritis and Cartilage, 2018 - europepmc.org
Objective To investigate the efficacy of CRISPR-Cas9 mediated editing in human
chondrocytes, and to develop a genome editing approach relevant to cell-based repair …
chondrocytes, and to develop a genome editing approach relevant to cell-based repair …